Artículos relacionados a Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis...
Sinopsis
Gleaning information from more than 100 experts in the field of cancer diagnosis, prognosis, and therapy worldwide, Cancer Biomarkers: Non-Invasive Early Diagnosis and Prognosis determines the significance of clinical validation approaches for several markers. This book examines the use of noninvasive or minimally invasive molecular cancer markers that are under development or currently in use. It deals with a majority of commonly prevalent cancers and can help anyone working in the health-care industry to recommend or develop early diagnostics, at-risk tests, and prognostic biomarkers for various cancers.
It explores the practice of determining biomarkers by their characteristics and relative methodologies, and presents the most recent data as well as a number of current and upcoming early diagnostic noninvasive molecular markers for many common cancers. It also considers the sensitivity and specificity of markers, biomarker market, test providers, and patent information.
Approximately 30-35 Cancer Specific Noninvasive Molecular Diagnostic Markers in a Single Volume
The book details the general and technical aspects of noninvasive cancer markers. It covers imaging, cutting-edge molecular technologies for biomarker development, and noninvasive or minimally invasive sources of molecular markers, as well as quality control and ethical issues in cancer biomarker discovery. It also provides a detailed account of brain, head and neck, and oral cancer markers, and provides information on a number of gastrointestinal cancers, lung cancer, and mesothelioma markers.
Emphasizes the Importance of Volatile Markers in Early Cancer Diagnosis
- Presents noninvasive early molecular markers in urological cancers
- Describes gynecological and endocrine cancer markers
- Details noninvasive markers of breast, ovarian, cervical, and thyroid cancers
- Addresses hematological malignancies
- Contains information on noninvasive molecular markers in myelodysplastic syndromes, acute myeloid leukemia, Hodgkin’s lymphoma, and multiple myeloma
- Provides comprehensive information on diagnostic and prognostic biomarkers in cutaneous melanoma
This text considers molecular technologies for biomarker development, noninvasive or minimally invasive sources of molecular markers, and quality control and ethical issues in cancer biomarker discovery.
"Sinopsis" puede pertenecer a otra edición de este libro.
Acerca del autor
Debmalya Barh (MSc, MTech, MPhil, PhD, PGDM) is the founder and president of the Institute of Integrative Omics and Applied Biotechnology (IIOAB), India. He is a consultant biotechnologist and an active researcher in integrative omics–based biomarkers, targeted drug discovery, and personalized medicine in cancer, neurodisorders, and cardiovascular, infectious, and metabolic diseases. He works with nearly 400 esteemed researchers from 30–35 countries and he has more than 100 high-impact publications. He has edited ten books in the field of omics. He also serves as an editorial and review board member for several highly respected international journals.
Dr. Angelo Carpi
is a clinical professor of medicine at the Pisa University Medical School, Pisa, Italy. He received his MD and postgraduate diplomas in internal medicine and nuclear medicine from the University of Pisa and his diploma of qualification on peptide hormones from the Collegio Medico Giuridico-Scuola Normale Superiore and the Scuola Superiore Sant’Anna, Pisa, Italy. His clinical practice and research included thyroid and breast tumors. He has authored about 300 publications included in PubMed. He is a member of the editorial boards of international journals such as Biomedicine & Pharmacotherapy and Frontiers in Bioscience.Dr. Mukesh Verma
is a program director and chief in the Methods and Technologies Branch (MTB), Epidemiology and Genomics Research Program (EGRP) of the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI), National Institutes of Health (NIH). Dr. Verma received his MSc from Pantnagar University and his PhD from Banaras Hindu University. He did postdoctoral research at George Washington University and was a faculty member at Georgetown University. He has published 128 research articles, book chapters, and reviews, and has edited three books in the field of cancer epigenetics and epidemiology.Mehmet Gunduz, MD, PhD
, is a professor of otolaryngology and medical genetics, Faculty of Medicine, Turgut Ozal University, Turkey. He graduated from Medical School Hacettepe University in 1990, and completed his residency in otolaryngology at the same university. He received his PhD from Okayama University and Wakayama Medical University, Japan, and is medical board certified from both the Turkish and Japanese certification authorities. One of the pioneers in identifying ING family tumor suppressors, Dr. Gunduz has contributed to more than 150 international publications, 3,000 citations, several book chapters, and over 200 presentations in national and international conferences."Sobre este título" puede pertenecer a otra edición de este libro.
EUR 309,07
EUR 28,63 gastos de envío desde Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envíoComprar nuevo
Ver este artículo
EUR 167,35
GRATIS gastos de envío en Estados Unidos de America
Destinos, gastos y plazos de envío
Resultados de la búsqueda para Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis...
Imagen de archivo
Cancer Biomarkers
Librería: Basi6 International, Irving, TX, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Condición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Nº de ref. del artículo: ABEOCT25-165003
Cantidad disponible: 1 disponibles
Imagen de archivo
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
Librería: Chiron Media, Wallingford, Reino Unido
Calificación del vendedor: 4 de 5 estrellas
Hardcover. Condición: New. Nº de ref. del artículo: 6666-TNFPD-9781466584280
Gastos de envío:
EUR 17,74
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 5 disponibles
Imagen de archivo
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
Librería: Mispah books, Redhill, SURRE, Reino Unido
Calificación del vendedor: 4 de 5 estrellas
Hardcover. Condición: Like New. Like New. Ships from Multiple Locations. book. Nº de ref. del artículo: ERICA77314665842896
Gastos de envío:
EUR 28,63
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 1 disponibles
Imagen de archivo
Cancer Biomarkers
Publicado por
Taylor & Francis Group, 2014
ISBN 10: 1466584289
ISBN 13: 9781466584280
Nuevo
Tapa dura
Librería: Majestic Books, Hounslow, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: New. pp. 973 16 page color insert (33 images) follows page 456 This item is printed on demand. Nº de ref. del artículo: 55133116
Gastos de envío:
EUR 7,44
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 3 disponibles
Imagen del vendedor
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
Librería: moluna, Greven, Alemania
Calificación del vendedor: 4 de 5 estrellas
Gebunden. Condición: New. Nº de ref. del artículo: 595957316
Gastos de envío:
EUR 48,99
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: Más de 20 disponibles
Imagen de archivo
Cancer Biomarkers
Publicado por
Taylor & Francis Group, 2014
ISBN 10: 1466584289
ISBN 13: 9781466584280
Nuevo
Tapa dura
Librería: Books Puddle, New York, NY, Estados Unidos de America
Calificación del vendedor: 4 de 5 estrellas
Condición: New. pp. 973 1st Edition. Nº de ref. del artículo: 2654459491
Cantidad disponible: 3 disponibles
Imagen de archivo
Cancer Biomarkers
Publicado por
Taylor & Francis Group, 2014
ISBN 10: 1466584289
ISBN 13: 9781466584280
Nuevo
Tapa dura
Librería: Biblios, Frankfurt am main, HESSE, Alemania
Calificación del vendedor: 5 de 5 estrellas
Condición: New. pp. 973. Nº de ref. del artículo: 1854459497
Gastos de envío:
EUR 9,95
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 3 disponibles
Imagen del vendedor
Cancer Biomarkers : Minimal and Noninvasive Early Diagnosis and Prognosis
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Calificación del vendedor: 5 de 5 estrellas
Buch. Condición: Neu. Neuware - This book classifies available tumor markers according to their principal characteristics and relative methodologies. It presents and discusses the use of the principal tumor markers available for the management of specific cancers (brain, head and neck, oral, gastrointestinal, lung and mesotelioma, urological, gynecological, thyroid, hematological, and melanoma). Each chapter focuses on one type of cancer and is written by physicians or scientists from various countries who blend their clinical experience and scientific expertise in new technologies to provide a definitive account of cancer biomarker discoveries. Nº de ref. del artículo: 9781466584280
Gastos de envío:
EUR 69,23
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío
Cantidad disponible: 2 disponibles